
    <!DOCTYPE html>
        <html>
        <head>
        <meta content="width=device-width, initial-scale=1" name="viewport" />
        <style>
@media only screen and (min-width:601px){
  .all {
    padding-left: 35%;
    padding-right: 35%;
    
  }
}

@media only screen and (max-width: 600px) {
  .all {
    padding-left: 5%;
    padding-right: 5%;

  }
}

body {
  margin-bottom:20%;
  padding-top: 5%;
}

h1 {
  text-align: center;
}

a {
  color: black;
  text-decoration: none;
}

.topnav {
  background-color: #333;
  overflow: hidden;
  position: fixed;
  width: 100%;
  top: 0;
}

.topnav a {
  float: left;
  color: #f2f2f2;
  text-align: center;
  padding: 14px 16px;
  text-decoration: none;
  font-size: 17px;
}

.topnav a:hover {
  background-color: #ddd;
  color: black;
}

.link:hover {
  color: blue;
}
        </style>
        <title>HEALTH SUMMARIES</title>
        </head>
        <body>
        <div class = 'topnav'>
        <a class='active' href='/'> Front Page</a>
        <a href="/news">News</a>
        <a href="/health">Health</a>
        <a href="/pharma">Pharma</a>
        </div>
        <div class='all'><h4>2019-02-06 20:12</h4><h1><a href='https://www.fiercebiotech.com/'>Fierce Biotech</a></h1><h3><a class='link' href='https://www.fiercebiotech.com/biotech/amid-r-d-rejigs-glaxosmithkline-axes-6-pipeline-assets'>Amid R&D rejigs, GlaxoSmithKline axes 6 pipeline assets</a></h3><h3><a class='link' href='https://www.fiercebiotech.com/biotech/chimerix-s-ceo-departs-and-replaced-by-a-trio-officers'>Chimerix’s CEO departs and is replaced by a trio of officers</a></h3><h3><a class='link' href='https://www.fiercebiotech.com/medtech/slack-telegraphs-moves-into-healthcare-as-it-gears-up-for-ipo-report'>Slack telegraphs moves into healthcare as it gears up for IPO</a></h3><h3><a class='link' href='https://www.fiercebiotech.com/biotech/avrobio-posts-encouraging-update-for-fabry-gene-therapy-phase-1-2-trials'>Avrobio posts encouraging update for Fabry gene therapy trials</a></h3><h3><a class='link' href='https://www.fiercebiotech.com/biotech/lilly-cuts-a-trio-pipeline-assets-including-btk-inhibitor-diabetes-med'>Lilly cuts a trio of pipeline assets, including BTK inhibitor</a></h3><br><h1><a href='https://www.biospace.com/news/'>BioSpace</a></h1><h3><a class='link' href='https://www.biospace.com/article/trump-s-sotu-claim-of-biggest-decline-in-prescription-drug-prices-is-for-a-one-month-period/'>Trump’s SOTU Claim of Biggest Decline in Prescription Drug Prices Is for a One Month Period</a></h3><h3><a class='link' href='https://www.biospace.com/article/gsk-cuts-six-respiratory-assets-as-it-continues-to-focus-on-oncology-treatments/'>GSK Cuts Six Respiratory Assets as It Continues to Focus on Oncology Treatments</a></h3><h3><a class='link' href='https://www.biospace.com/article/gladstone-institutes-robert-mahley-launches-alzheimer-s-biotech-gabaeron/'>Gladstone Institutes’ Robert Mahley Launches Alzheimer’s Biotech GABAeron</a></h3><h3><a class='link' href='https://www.biospace.com/article/-where-are-they-now-top-3-biotech-startups-from-nextgen-bio-2016_10/'> Where Are They Now? Top 3 Biotech Startups From NextGen Bio 2016</a></h3><h3><a class='link' href='https://www.biospace.com/article/eli-lilly-q4-strong-volume-growth-and-lowered-2019-guidance/'>Eli Lilly's Lartruvo Failure Puts a Crimp in Its Plans for the Oncology Market</a></h3></div></body>
        </html>